OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research
Sergiu Chira, Andreea Nuțu, Ecaterina Isacescu, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2781-2781
Open Access | Times Cited: 12

Showing 12 citing articles:

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 72

An Update on the Application of CRISPR Technology in Clinical Practice
Firouzeh Morshedzadeh, Mahmoud Ghanei, Malihe Lotfi, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 2, pp. 179-197
Open Access | Times Cited: 25

CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine
Dilip Kumar Chanchal, Jitendra Singh Chaudhary, Pushpendra Kumar, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 3, pp. 193-207
Closed Access | Times Cited: 10

Nano-Engineering for Precision Oncology Unraveling Molecular Mechanisms and Pioneering Revolutionary Cancer Therapies
Ayesha Liaqat, Maaz Ghouri, Raheela Shehzadi, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 3, pp. 9-18
Closed Access

Gene editing techniques in cancer research
Nurhasni Hasan, Juliana Palungan, Muneeb Ullah
Methods in cell biology (2025)
Closed Access

Expanding Horizons of CRISPR/Cas Technology: Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy
Ahmad Bairqdar, Polina E. Karitskaya, Г. А. Степанов
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13321-13321
Open Access | Times Cited: 2

Shedding light on the dark genome: Insights into the genetic, CRISPR-based, and pharmacological dependencies of human cancers and disease aggressiveness
Doris Kafita, Panji Nkhoma, Kevin Dzobo, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0296029-e0296029
Open Access | Times Cited: 4

Gene Therapy Advancements for Precision Cancer Treatment: Challenges and Opportunities in Sub-Saharan Africa – Nigeria Perspective
A Sheudeen Abubakar, Ibitoroko George-Opuda, A Anthony, et al.
Asian Journal of Biochemistry Genetics and Molecular Biology (2024) Vol. 16, Iss. 1, pp. 25-35
Open Access | Times Cited: 1

Targeting DLBCL by mutation-specific disruption of cancer-driving oncogenes
Najmeh Heshmatpour, Sohrab Kazemi, Niklas Schmidt, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access

The Applications of Genome Editing in the Management of Cancer: A Narrative Overview
Ismail Ibrahim Al-Janabi
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 6, Iss. 1, pp. 76-85
Open Access

Molecular Mechanisms of Breast Cancer Drug Resistance and CRISPR/Cas9 Strategies to Overcome
Bashdar Mahmud Hussen, Bnar Saleh Ismael, Saman S. Abdulla, et al.
BioMed Target Journal (2024) Vol. 2, Iss. 2, pp. 1-20
Open Access

Page 1

Scroll to top